- Home
- VEEE vs XRTX Comparison
VEEE vs XRTX Comparison
Compare VEEE & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- XRTX
- Stock Information
- Founded
- VEEE 1994
- XRTX 2011
- Country
- VEEE United States
- XRTX Canada
- Employees
- VEEE N/A
- XRTX N/A
- Industry
- VEEE Marine Transportation
- XRTX Pharmaceuticals and Biotechnology
- Sector
- VEEE Industrials
- XRTX Health Care
- Exchange
- VEEE Nasdaq
- XRTX Nasdaq
- Market Cap
- VEEE 4.7M
- XRTX 4.1M
- IPO Year
- VEEE 2021
- XRTX N/A
- Fundamental
- Price
- VEEE $0.34
- XRTX $1.15
- Analyst Decision
- VEEE
- XRTX Strong Buy
- Analyst Count
- VEEE 0
- XRTX 1
- Target Price
- VEEE N/A
- XRTX $14.00
- AVG Volume (30 Days)
- VEEE 62.1K
- XRTX 15.6K
- Earning Date
- VEEE 11-14-2024
- XRTX 11-15-2024
- Dividend Yield
- VEEE N/A
- XRTX N/A
- EPS Growth
- VEEE N/A
- XRTX N/A
- EPS
- VEEE N/A
- XRTX N/A
- Revenue
- VEEE $20,949,492.00
- XRTX N/A
- Revenue This Year
- VEEE $76.99
- XRTX N/A
- Revenue Next Year
- VEEE N/A
- XRTX N/A
- P/E Ratio
- VEEE N/A
- XRTX N/A
- Revenue Growth
- VEEE N/A
- XRTX N/A
- 52 Week Low
- VEEE $0.33
- XRTX $1.09
- 52 Week High
- VEEE $1.64
- XRTX $7.00
- Technical
- Relative Strength Index (RSI)
- VEEE 33.96
- XRTX 40.84
- Support Level
- VEEE $0.35
- XRTX $1.14
- Resistance Level
- VEEE $0.50
- XRTX $1.25
- Average True Range (ATR)
- VEEE 0.05
- XRTX 0.09
- MACD
- VEEE -0.00
- XRTX 0.01
- Stochastic Oscillator
- VEEE 6.67
- XRTX 10.71
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.